2018
DOI: 10.1002/mp.12861
|View full text |Cite
|
Sign up to set email alerts
|

Development of a measure for evaluating lesion‐wise performance of CAD algorithms in the context of mpMRI detection of prostate cancer

Abstract: The proposed measures allow for the assessment of lesion detection performance, which is most relevant in a clinical setting and would not be possible to do with voxel-wise measures alone.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 28 publications
0
5
0
Order By: Relevance
“…Another future direction is cancer lesion identification using voxel-wise mpMRI data, which is challenging and has so far received limited attention. 29,30 We are currently discussing voxel-wise PCa classification, which is the focus of the majority of the mpMRI classifiers. However, clinical practice requires that the results are eventually translated into detection of cancer lesions, which can be a better guidance for clinical decision, and determining how best to identify lesions using voxel-wise data is worthy of investigation.…”
Section: Discussionmentioning
confidence: 99%
“…Another future direction is cancer lesion identification using voxel-wise mpMRI data, which is challenging and has so far received limited attention. 29,30 We are currently discussing voxel-wise PCa classification, which is the focus of the majority of the mpMRI classifiers. However, clinical practice requires that the results are eventually translated into detection of cancer lesions, which can be a better guidance for clinical decision, and determining how best to identify lesions using voxel-wise data is worthy of investigation.…”
Section: Discussionmentioning
confidence: 99%
“…The average sensitivity for cancer detection for all relevant studies was 86.8% [14 -31]. For all studies, peak sensitivity was 98% and lowest was 46.8% (25,30). The average specificity of CAD was 79.8% [14 -31].…”
Section: Cad Sensitivity and Specificity Versus Radiologistsmentioning
confidence: 99%
“…Quantitative T2 mapping provides a more objective and potentially sensitive imaging biomarker for diagnosis and grading of prostate cancer compared to qualitative T2-weighted imaging [1][2][3][4] .…”
Section: Introductionmentioning
confidence: 99%